MENU
+Compare
RMOP
ETF ticker: NYSE ARCA
AS OF
Feb 3 closing price
Price
$25.07
Change
+$0.02 (+0.10%)

RMOP Rockefeller Opportunistic Muncpl Bd ETF Forecast, Technical & Fundamental Analysis

The investment seeks current income exempt from federal income tax and to seek long-term capital appreciation... Show more

RMOP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for RMOP with price predictions
Feb 02, 2026

RMOP sees its Stochastic Oscillator ascending out of oversold territory

On January 23, 2026, the Stochastic Oscillator for RMOP moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 14 instances where the indicator left the oversold zone. In of the 14 cases the stock moved higher in the following days. This puts the odds of a move higher at over .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on February 02, 2026. You may want to consider a long position or call options on RMOP as a result. In of 22 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

RMOP moved above its 50-day moving average on December 29, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RMOP crossed bullishly above the 50-day moving average on January 06, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 5 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RMOP advanced for three days, in of 103 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 83 cases where RMOP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for RMOP moved out of overbought territory on January 08, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 8 similar instances where the indicator moved out of overbought territory. In of the 8 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for RMOP turned negative on January 20, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 12 similar instances when the indicator turned negative. In of the 12 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RMOP declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RMOP broke above its upper Bollinger Band on January 07, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

View a ticker or compare two or three
RMOP
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category HighYieldMuni

Profile
Fundamentals
Details
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AENT7.710.80
+11.58%
Alliance Entertainment Holding Corp
SNDX21.351.04
+5.12%
Syndax Pharmaceuticals
GSRFU10.28N/A
N/A
GSR IV Acquisition Corp.
EGP180.44-1.20
-0.66%
EastGroup Properties
PMVP1.06-0.02
-1.85%
PMV Pharmaceuticals